ONC
ONC
US07725L1026
BeOne Medicines Ltd.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 5.343.033.000 3.810.241.000
40.2%
Cost of Revenue 668.540.000 594.089.000
12.5%
Gross Profit 4.674.493.000 3.216.152.000
45.3%
4.227.357.000 3.784.351.000
11.7%
Operating Income 447.136.000 -568.199.000
178.7%
Pretax Income 416.854.000 -533.001.000
178.2%
Net Income Common Stockholders 286.933.000 -644.786.000
144.5%
-- --
--
-- --
--
ende